Venus concept receives 510(k) clearance for the venus versa pro system, its new multi-application platform

Toronto, sept. 14, 2023 (globe newswire) -- venus concept inc. ("venus concept" or the "company") (nasdaq: vero), a global medical aesthetic technology leader, announced today that it has received a 510(k) clearance from the u.s. food and drug administration (“fda”) to market its venus versa pro system, the company's new multi-application platform, for a variety of aesthetic and cosmetic procedures.
VERO Ratings Summary
VERO Quant Ranking